The novel hyaluronic acid granular hydrogel attenuates osteoarthritis progression by inhibiting the TLR‐2/NF‐κB signaling pathway through suppressing cellular senescence

In patients with mild osteoarthritis (OA), two to four monthly injections are required for 6 months due to the degradation of hyaluronic acid (HA) by peroxidative cleavage and hyaluronidase. However, frequent injections may lead to local infection and also cause inconvenience to patients during the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chen, Cheng, Zhengxiang, Zhou, Yuanyuan, Yu, Ziyi, Mai, Hongyu, Xu, Changhao, Zhang, Jing, Wang, Jiali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189429/
https://www.ncbi.nlm.nih.gov/pubmed/37206234
http://dx.doi.org/10.1002/btm2.10475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189429/
https://www.ncbi.nlm.nih.gov/pubmed/37206234
http://dx.doi.org/10.1002/btm2.10475

Ejemplares similares